CRISPR-Based Correction of Rare Immune Disorder, Wiskott-Aldrich Syndrome

CRISPR is believed to hold the cure for many rare single-gene disorders that are otherwise incurable. Alessia Cavazza’s group at University College London recently deployed the technology to correct the gene implicated in the rare immune disorder, Wiskott-Aldrich Syndrome. You can read the story in our latest piece.

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers!

Happy Reading!

Karen

p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.